Osteoporosis: Therapeutic Options

The definition of osteoporosis was originally formulated at a conference of the World Health Organization (WHO) in 1993 as ‘a systemic skeletal disease characterized by decreased bone mass and altered micro-architecture of bone tissue, leading to enhanced bone fragility and risk of fractures’. Osteo...

Full description

Bibliographic Details
Main Authors: Ivanova Stefka, Vasileva Liliya, Ivanova Stanislava, Peikova Lily, Obreshkova Danka
Format: Article
Language:English
Published: Pensoft Publishers 2015-12-01
Series:Folia Medica
Subjects:
Online Access:http://www.degruyter.com/view/j/folmed.2015.57.issue-3-4/folmed-2015-0037/folmed-2015-0037.xml?format=INT
id doaj-b75d1eb7b12340809bbaa3c61d7599de
record_format Article
spelling doaj-b75d1eb7b12340809bbaa3c61d7599de2020-11-25T01:32:38ZengPensoft PublishersFolia Medica 1314-21432015-12-01573-418119010.1515/folmed-2015-0037folmed-2015-0037Osteoporosis: Therapeutic OptionsIvanova Stefka0Vasileva Liliya1Ivanova Stanislava2Peikova Lily3Obreshkova Danka4Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Sofia, Bulgaria Department of Pharmacology and Clinical Pharmacology, Faculty of Pharmacy, Medical University Plovdiv, Bulgaria, 15A Vassil Aprilov Blvd., 4002 Plovdiv, Bulgaria Department of Pharmacognosy and Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Plovdiv, Bulgaria Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Sofia, Bulgaria Department of Pharmacognosy and Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Plovdiv, Bulgaria The definition of osteoporosis was originally formulated at a conference of the World Health Organization (WHO) in 1993 as ‘a systemic skeletal disease characterized by decreased bone mass and altered micro-architecture of bone tissue, leading to enhanced bone fragility and risk of fractures’. Osteoporosis is characterized by low bone mineral density (BMD) and loss of the structural and bio-mechanical properties that are required to maintain bone homeostasis. This review aims to address the currently available options in prevention and treatment of osteoporosis. Management of osteoporosis includes non-pharmacological treatment - diet rich of calcium and vitamin D, healthy lifestyle, proper exercise plan, and pharmacological therapy. Combination of non-pharmacological and pharmacological treatment options have to be considered for prevention of osteoporosis and minimization of the risk of fractures. Given the heterogeneity of osteoporosis syndrome and lack of significant number of comparative studies, the choice of a pharmacological agents should be individualized.http://www.degruyter.com/view/j/folmed.2015.57.issue-3-4/folmed-2015-0037/folmed-2015-0037.xml?format=INTosteoporosistreatmentpreventionpharmacologystructure-activity
collection DOAJ
language English
format Article
sources DOAJ
author Ivanova Stefka
Vasileva Liliya
Ivanova Stanislava
Peikova Lily
Obreshkova Danka
spellingShingle Ivanova Stefka
Vasileva Liliya
Ivanova Stanislava
Peikova Lily
Obreshkova Danka
Osteoporosis: Therapeutic Options
Folia Medica
osteoporosis
treatment
prevention
pharmacology
structure-activity
author_facet Ivanova Stefka
Vasileva Liliya
Ivanova Stanislava
Peikova Lily
Obreshkova Danka
author_sort Ivanova Stefka
title Osteoporosis: Therapeutic Options
title_short Osteoporosis: Therapeutic Options
title_full Osteoporosis: Therapeutic Options
title_fullStr Osteoporosis: Therapeutic Options
title_full_unstemmed Osteoporosis: Therapeutic Options
title_sort osteoporosis: therapeutic options
publisher Pensoft Publishers
series Folia Medica
issn 1314-2143
publishDate 2015-12-01
description The definition of osteoporosis was originally formulated at a conference of the World Health Organization (WHO) in 1993 as ‘a systemic skeletal disease characterized by decreased bone mass and altered micro-architecture of bone tissue, leading to enhanced bone fragility and risk of fractures’. Osteoporosis is characterized by low bone mineral density (BMD) and loss of the structural and bio-mechanical properties that are required to maintain bone homeostasis. This review aims to address the currently available options in prevention and treatment of osteoporosis. Management of osteoporosis includes non-pharmacological treatment - diet rich of calcium and vitamin D, healthy lifestyle, proper exercise plan, and pharmacological therapy. Combination of non-pharmacological and pharmacological treatment options have to be considered for prevention of osteoporosis and minimization of the risk of fractures. Given the heterogeneity of osteoporosis syndrome and lack of significant number of comparative studies, the choice of a pharmacological agents should be individualized.
topic osteoporosis
treatment
prevention
pharmacology
structure-activity
url http://www.degruyter.com/view/j/folmed.2015.57.issue-3-4/folmed-2015-0037/folmed-2015-0037.xml?format=INT
work_keys_str_mv AT ivanovastefka osteoporosistherapeuticoptions
AT vasilevaliliya osteoporosistherapeuticoptions
AT ivanovastanislava osteoporosistherapeuticoptions
AT peikovalily osteoporosistherapeuticoptions
AT obreshkovadanka osteoporosistherapeuticoptions
_version_ 1725080821150253056